Clinical Trial Update: NMDA Receptor Modulation for the Treatment of Bipolar I Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an NMDA receptor modulation approach for treating Bipolar I Disorder is currently recruiting, sponsored by China Medical Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Investigational NMDA receptor modulator

Snippet

Sponsor: China Medical University Hospital | Conditions: Bipolar I Disorder | Phase 2 | Status: RECRUITING